bronchiol
common
pediatr
ailment
occur
children
age
year
often
month
age
respons
larg
number
hospit
push
resourc
util
medic
cost
consider
american
academi
pediatr
publish
systemat
review
diagnosi
treatment
bronchiol
attempt
standard
diagnost
test
medic
use
subsequ
revis
recommend
publish
american
academi
pediatr
view
streamlin
diagnosi
manag
turn
reduc
econom
burden
due
diseas
bronchiol
viral
infect
lower
respiratori
tract
often
caus
respiratori
syncyti
viru
rsv
account
case
initi
year
life
less
commonli
virus
like
human
rhinoviru
human
metapneumoviru
influenza
parainfluenza
adenoviru
coronaviru
mayb
respons
diseas
process
accord
denni
et
al
sever
case
occur
age
month
associ
high
morbid
mortal
larg
number
case
presum
unknown
etiolog
organ
isol
howev
data
studi
done
denney
et
al
show
case
refer
rsv
infect
viral
infect
character
acut
inflamm
edema
necrosi
epitheli
cell
line
small
airway
associ
increas
mucu
product
bronchospasm
chang
respons
symptom
sign
associ
bronchiol
econom
burden
diseas
number
hospit
due
bronchiol
excess
high
data
collect
nation
hospit
discharg
survey
shown
increas
acut
bronchiol
hospit
rate
among
infant
age
year
among
age
year
accord
pelleti
et
al
bronchiol
hospit
respons
stagger
expens
million
annual
huge
burden
exist
healthcar
resourc
leader
kohlhas
estim
ed
visit
infant
lower
respiratori
infect
subsequ
diagnos
bronchiol
case
admit
total
cost
hospit
amount
billion
bronchiol
recogn
constel
sign
symptom
aid
diagnosi
diseas
usual
begin
viral
upper
respiratori
infect
lead
increas
respiratori
effort
wheez
children
year
age
respiratori
rate
high
relat
infant
age
month
normal
respiratori
rate
min
reduc
min
month
count
min
conclud
presenc
distress
accord
aap
guidelin
respiratori
rate
min
consid
suggest
tachypnea
absenc
tachypnea
rule
risk
signific
sever
viral
bacteri
lower
respiratori
infect
presenc
tachypnea
help
distinguish
viral
bacteri
infect
current
recommend
strongli
suggest
bronchiol
must
diagnos
clinician
base
histori
physic
examin
patient
cours
diseas
dynam
could
vari
time
time
henc
infant
must
continu
monitor
improv
well
sudden
deterior
condit
transient
apnea
may
found
occur
period
may
progress
respiratori
distress
due
lower
airway
obstruct
underli
morbid
factor
may
caus
rapid
progress
deterior
infant
condit
prematur
underli
cardiac
chronic
pulmonari
diseas
immunodefici
previou
episod
wheez
may
result
hemodynam
instabl
congenit
cardiac
anomali
bronchopulmonari
dysplasia
congenit
anomali
utero
exposur
smoke
could
compromis
statu
worsen
present
condit
genet
abnorm
associ
sever
episod
bronchiol
prematur
particularli
associ
sever
rsv
infect
prematur
infant
higher
degre
risk
hospit
compar
late
preterm
underli
anomali
must
assess
clinician
evalu
manag
case
bronchiol
recommend
aap
moder
strength
improv
abil
predict
cours
ill
possibl
avoid
unnecessari
hospit
hypoxemia
may
associ
tachypnea
develop
bronchiol
accord
studi
rajesh
et
al
tachypnea
good
predictor
hypoxia
infant
age
month
puls
oximetri
use
method
detect
fall
level
oxygen
satur
may
miss
physic
assess
case
control
studi
done
aljanabi
et
al
identifi
predictor
hypoxemia
acut
lower
respiratori
tract
infect
children
found
signific
associ
presenc
tachypnea
hypoxemia
conclud
puls
oximetri
desir
accur
identifi
hypoxemia
howev
studi
valid
effect
puls
oximetri
predict
clinic
outcom
studi
gambian
infant
report
usen
et
al
reiter
simpl
physic
sign
pick
minimum
expertis
use
guid
oxygen
therapi
current
aap
guidelin
provid
weak
recommend
clinician
need
use
continu
puls
oximetri
infant
children
diagnosi
bronchiol
recommend
may
decreas
length
stay
hospit
well
reduc
minor
advers
effect
like
alarm
fatigu
certainli
reduc
hospit
cost
howev
import
puls
oximetri
negat
conveni
rel
easi
method
assess
percentag
hemoglobin
bound
oxygen
provid
consid
proxi
respiratori
distress
accuraci
puls
oximetri
drop
rang
level
small
increas
arteri
puls
pressur
associ
signific
improv
puls
oxygen
satur
howev
data
exist
regard
improv
patient
symptom
physiolog
function
clinic
outcom
associ
increas
satur
henc
use
puls
oximetri
monitor
children
bronchiol
would
clinician
discret
mention
aljanabi
et
al
puls
oximetri
best
indic
hypoxemia
children
although
rel
expens
use
may
cost
effect
control
oxygen
requir
diagnosi
bronchiol
usual
base
clinic
symptom
sign
wherein
infant
tachypnea
minim
sign
auscult
chest
upper
airway
obstruct
predominantli
respons
work
breath
current
aap
guidelin
moder
strength
support
need
chest
radiographi
routin
suspect
case
bronchiol
studi
shown
infant
initi
radiographi
would
like
receiv
antibiot
other
yet
demonstr
signific
differ
outcom
accord
guidelin
initi
radiographi
must
restrict
case
tachypnea
present
sever
enough
warrant
admiss
directli
icu
suspect
possibl
complic
like
pneumothorax
would
requir
aggress
manag
test
viru
type
respons
infect
may
signific
area
routin
season
antirsv
prophylaxi
administ
larg
studi
shown
almost
posit
rsv
infect
leader
et
al
retrospect
analysi
data
collect
show
least
visit
ed
infant
lower
respiratori
infect
attribut
rsv
infect
rsv
bronchiol
lead
caus
hospit
et
al
review
data
hospit
admiss
lower
respiratori
tract
infect
found
annual
incid
hospit
admiss
attribut
rsv
children
year
children
year
age
case
specif
organ
isol
denni
et
al
suggest
larg
number
case
organ
isol
could
caus
rsv
infect
includ
season
infect
caus
rsv
could
confound
diagnosi
human
rhinoviru
caus
bronchiol
associ
shorter
cours
could
caus
prolong
viral
shed
accur
identif
viru
alter
cours
treatment
outcom
henc
routin
viral
test
recommend
children
receiv
monthli
palivizumab
prophylaxi
case
breakthrough
rsv
confirm
recommend
discontinu
prophylaxi
second
rsv
infect
highli
unlik
year
oxygen
administr
found
improv
satur
level
howev
level
take
larg
elev
arteri
partial
pressur
increas
satur
henc
weak
recommend
given
clinician
may
choos
administ
supplement
oxygen
oxyhemoglobin
satur
exce
infant
children
bronchiol
administr
high
flow
oxygen
nasal
cannula
increasingli
recommend
prefer
mode
oxygen
administr
specif
children
bronchiol
moder
sever
intens
high
flow
nasal
cannula
hfnc
design
way
deliv
mixtur
air
oxygen
heat
humidifi
flow
higher
patient
inspiratori
flow
studi
shown
hfnc
use
overcom
obstruct
apnea
prevent
pharyng
collaps
provid
inspiratori
support
besid
specif
usag
bronchiol
could
decreas
electr
activ
diaphragm
decreas
esophag
pressur
swing
reduc
work
breath
decreas
work
breath
shown
variou
studi
hfnc
feasibl
well
toler
shown
produc
good
result
especi
case
moder
intens
may
room
cpapniv
treatment
modal
larg
studi
perform
australia
shown
signific
declin
rate
intub
infant
diagnos
bronchiol
reduct
case
random
trial
conduct
et
al
two
urban
secondari
pediatr
hospit
unit
estim
extent
benefit
could
deriv
patient
bronchiol
use
high
frequenc
humidifi
nasal
cannula
oxygen
therapi
report
studi
show
benefici
valu
use
humidifi
oxygen
nasal
cannula
compar
use
hyperton
salin
term
decreas
sever
improv
comfort
level
despit
hfnc
continu
popular
therapi
infant
bronchiol
proven
use
reduc
requir
intub
well
welltoler
noninvas
form
respiratori
support
percept
sinc
long
time
bronchiol
requir
use
bronchodil
order
improv
oxygen
satur
decreas
respiratori
distress
associ
ill
accord
current
guidelin
strong
recommend
bronchodil
like
salbutamol
must
administ
infant
bronchiol
recommend
base
report
sever
studi
review
show
benefit
use
badrenerg
agent
term
improv
diseas
resolut
need
hospit
length
stay
studi
eber
also
shown
benefit
potenti
advers
effect
term
tachypnea
cost
agent
outweigh
possibl
benefit
cochran
databas
system
review
trial
evalu
role
bronchodil
bronchiol
shown
improv
oxygen
satur
decreas
length
hospit
aap
guidelin
provid
strong
recommend
use
epinephrin
case
bronchiol
studi
done
compar
effect
epinephrin
versu
salbutamol
decreas
inpati
outcom
length
hospit
improv
found
either
paramet
random
control
trial
report
wainwright
et
al
role
nebul
epinephrin
acut
bronchiol
reduct
length
hospit
stay
time
till
discharg
infant
possibl
role
epinephrin
could
rescu
agent
case
sever
bronchiol
absenc
formal
studi
definit
recommend
use
anoth
strong
recommend
place
system
corticosteroid
role
manag
acut
viral
bronchiol
base
lack
benefici
effect
possibl
corticosteroid
may
increas
durat
viral
shed
earlier
studi
shown
role
steroid
acceler
clinic
recoveri
children
hospit
acut
rsv
bronchiol
sever
studi
evalu
role
corticosteroid
given
via
nebul
rout
oral
parentar
draw
conclus
evid
regard
util
corticosteroid
acut
phase
follow
bronchiol
infect
larg
studi
rigidli
design
execut
cade
et
al
fail
show
benefit
administr
nebul
budesonid
could
due
poor
drug
deposit
lung
occur
due
tachypnea
ga
trap
increas
secret
associ
bronchiol
role
nebul
hyperton
salin
slightli
controversi
guidelin
suggest
moder
strong
recommend
use
er
weak
recommend
given
use
hospit
patient
studi
done
mandelberg
et
al
determin
use
nebul
hyperton
salin
children
admit
viral
bronchiol
studi
report
benefit
use
nebul
salin
hospit
patient
decreas
symptom
well
length
hospit
year
follow
studi
report
tal
et
al
pool
analyz
year
data
report
hyperton
salin
activ
drug
viral
bronchiol
effect
therapeut
modal
combin
mg
epinephrin
nebul
author
found
good
result
hospit
well
ambulatori
patient
cochran
databas
studi
favor
use
nebul
hyperton
salin
compar
normal
salin
treatment
acut
bronchiol
reduct
hospit
durat
well
improv
sever
score
strong
recommend
use
antibacteri
agent
patient
diagnos
viral
bronchiol
unless
evid
concomit
bacteri
infect
chest
physiotherapi
use
modal
treatment
sever
chronic
respiratori
diseas
wherein
increas
airway
hypersecret
random
control
studi
perform
seven
pediatr
depart
gajdo
et
al
includ
infant
rang
day
month
admit
first
episod
wheez
diagnos
acut
bronchiol
found
differ
recoveri
group
receiv
physiotherapi
control
group
nasal
suction
perform
anoth
studi
postiaux
et
al
report
new
techniqu
perform
chest
physiotherapi
consist
prolong
slow
expir
follow
provok
cough
manoeuvr
result
encourag
short
term
benefit
found
respiratori
symptom
maneuv
possibl
aid
mucu
drainag
assist
improv
symptom
cochran
databas
review
report
sever
studi
compar
physiotherapi
intervent
result
neg
chest
physiotherapi
includ
vibrat
percuss
techniqu
well
passiv
expiratori
techniqu
anoth
report
et
al
evalu
outcom
convent
chest
physiotherapi
found
signific
benefit
treatment
acut
bronchiol
current
guidelin
aap
moder
strong
one
recommend
use
chest
physiotherapi
infant
diagnos
bronchiol
concentr
symptom
reduct
make
patient
comfort
diseas
free
earliest
essenti
ensur
hydrat
nutrit
requir
adequ
address
need
intraven
nasogastr
fluid
unabl
maintain
adequ
hydrat
strongli
recommend
accord
verma
et
al
support
care
remain
cornerston
manag
infant
bronchiol
convent
iv
fluid
recommend
use
chanc
aspir
lower
interfer
breath
howev
prolong
usag
may
neg
catabol
state
due
calori
denial
henc
mani
countri
prefer
use
nasogastr
feed
better
nutrit
statu
ng
feed
may
administ
continu
case
major
respiratori
distress
bolu
therapi
recent
random
studi
shown
differ
outcom
iv
fluid
may
prefer
moder
sever
respiratori
difficulti
mark
tachypnea
apnea
episod
mark
tire
feed
anoth
suggest
indic
use
iv
fluid
patient
vomit
unabl
accept
oral
feed
suffici
fluid
must
administ
prevent
dehydr
role
palivizumab
recommend
first
year
life
high
risk
infant
signific
heart
diseas
chronic
lung
diseas
prematur
week
day
gestat
requir
oxygen
first
day
life
recommend
administr
otherwis
healthi
infant
week
day
gestat
age
author
none
declar
r
e
f
e
r
e
n
c
e
